Liu Johnson M, Ellis Steven R
Feinstein Institute for Medical Research, Manhasset, NY, USA.
Blood. 2006 Jun 15;107(12):4583-8. doi: 10.1182/blood-2005-12-4831. Epub 2006 Feb 28.
Gene products mutated in the inherited bone marrow failure syndromes dyskeratosis congenita (DC), cartilage-hair hypoplasia (CHH), Diamond-Blackfan anemia (DBA), and Shwachman-Diamond syndrome (SDS) are all predicted to be involved in different aspects of ribosome synthesis. At this moment, however, it is unclear whether this link indicates a causal relationship. Although defective ribosome synthesis may contribute to each of these bone marrow failure syndromes (and perhaps others), precisely which feature of each disease is a consequence of failure to produce adequate amounts of ribosomes is obscured by the tendency of each gene product to have extraribosomal functions. Delineation of the precise role of each gene product in ribosomal biogenesis and in hematopoietic development may have both therapeutic and prognostic importance and perhaps even direct the search for new bone marrow failure genes.
在遗传性骨髓衰竭综合征,如先天性角化不良(DC)、软骨毛发发育不全(CHH)、先天性纯红细胞再生障碍性贫血(DBA)和施-戴二氏综合征(SDS)中发生突变的基因产物,预计都参与核糖体合成的不同方面。然而,目前尚不清楚这种联系是否表明存在因果关系。尽管核糖体合成缺陷可能导致这些骨髓衰竭综合征中的每一种(也许还有其他综合征),但由于每个基因产物都具有核糖体以外的功能,每种疾病的确切特征中哪些是核糖体产量不足的结果仍不清楚。明确每个基因产物在核糖体生物发生和造血发育中的精确作用可能具有治疗和预后意义,甚至可能指导寻找新的骨髓衰竭基因。